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Summary
Krox20 is a zinc finger-containing transcription factor that is abundantly expressed in adipose tissue. However, its role in
fat cell differentiation has not been established. In cultured 3T3-L1 cells, Krox20 is rapidly induced by serum stimulation.
Overexpression of Krox20 in both 3T3-L1 preadipocytes and multipotent NIH3T3 cells promotes adipogenesis in a hor-
mone-dependent manner. Conversely, RNAi-mediated loss of Krox20 function reduced adipogenesis in 3T3-L1 cells. Ec-
topic expression of Krox20 can transactivate the C/EBPβ promoter and increase C/EBPβ gene expression in 3T3-L1 preadi-
pocytes. RNAi-mediated knockdown of C/EPBβ diminished Krox20’s proadipogenic effect. Finally, coexpression of Krox20
and C/EBPβ in naive NIH3T3 cells resulted in the pronounced induction of a fully differentiated adipocyte phenotype, an
effect previously observed only with PPARγ. These data indicate that Krox20 is necessary for adipogenesis and that, when
overexpressed, Krox20 potently stimulates adipogenesis via C/EBPβ-dependent and -independent mechanisms.Introduction
Obesity, the excess deposition of adipose tissue, is one of the
most pressing health problems in the Western and developing
world. Thus, the molecular events underlying the determination
and differentiation of adipose tissue are of basic and potential
clinical importance. The immortalized mouse adipogenic 3T3-
L1 and 3T3-F442A cell lines have been used extensively to
study these processes. When exposed to a cocktail of hor-
mones, 3T3-L1 cells change their appearance from that of fi-
broblasts to that of adipocytes. In these cells, the process of
adipocyte conversion follows a well-orchestrated program in
which the CCAAT/enhancer binding proteins C/EBPδ, C/EBPβ,
and C/EBPα (Cao et al., 1991; Umek et al., 1991; Yeh et al.,
1995) and the nuclear hormone receptor peroxisome prolifera-
tor-activated receptor γ (PPARγ) (Rosen et al., 2002; Tontonoz
et al., 1994) are sequentially activated and play pivotal roles.
C/EBPβ and C/EBPδ are among the first transcription factors
induced following exposure of preadipocytes to hormonal in-
ducers, and they are both stimulatory to adipogenesis (Yeh et
al., 1995). Loss-of-function studies have shown that C/EBPβ
and C/EBPδ have a synergistic and essential role in adipocyte
differentiation (Tanaka et al., 1997).
In contrast, naive 3T3 cells do not readily differentiate into
adipocytes when exposed to the same cocktail of hormones
that lead to the differentiation of 3T3-L1 cells. PPARγ is the
only factor capable of fully differentiating naive 3T3 cells into
adipocytes. Ectopic expression of C/EBPβ can also convert
multipotent NIH3T3 cells into mature adipocytes, but this effect
is much less robust than PPARγ, while C/EBPδ had no effect
on the adipocyte differentiation of these cells (Wu et al., 1995;
Yeh et al., 1995).
C/EBPβ can also promote the fat differentiation of 3T3-L1
cells. After exposure to a hormonal cocktail, C/EBPβ mRNA isCELL METABOLISM : FEBRUARY 2005 · VOL. 1 · COPYRIGHT © 2005 Eactively expressed and then begins to diminish around day 2
of hormonal induction, at which point the RNAs for C/EBPα
and PPARγ increase (Cao et al., 1991). C/EBPα and PPARγ in-
duce programs of gene expression leading to the differentiation
of mature adipocytes (Rosen et al., 2002; Lin and Lane, 1994;
Tontonoz et al., 1994). Loss-of-function genetic studies indi-
cate that PPARγ is absolutely required for differentiation (Rosen
et al., 1999); while C/EBPα is not strictly required for adipogen-
esis, it is required for insulin action (Rosen et al., 2002).
Recent studies have shown that a large number of other
transcription factors are expressed during adipogenesis in vitro
and in adipose tissue in vivo (Soukas et al., 2001). These data
have suggested that a set of complex transcriptional hierar-
chies and networks are responsible for the changes in cell
morphology and gene expression associated with adipocyte
differentiation. This network of transcription factors forms a
crossregulatory circuit whereby the differentiated state can not
only be initiated but also maintained.
In this report, we set out to identify additional factors capa-
ble of influencing adipocyte differentiation. We reasoned that
such factors would be enriched in adipose tissue in vivo where
adipogenesis normally takes place. In earlier studies of the
transcriptional programs associated with adipocyte develop-
ment in vitro and in vivo, we identified a panel of transcription
factors that are expressed at a much higher level in white adi-
pose tissues in vivo, as compared to mature adipocytes devel-
oped in vitro from 3T3-L1 preadipocytes (Soukas et al., 2001).
One of these genes, Krox20 transcription factor, was ex-
pressed at high levels in adipose tissue in vivo and at much
lower levels during adipogenesis in vitro. Krox20 was originally
isolated as an immediate-early response gene from serum-
stimulated NIH3T3 fibroblasts (Chavrier et al., 1988). Other
studies showed that Krox20 is expressed in developing em-
bryos and that it is tightly controlled temporally and spatiallyLSEVIER INC. DOI 10.1016/j.cmet.2004.12.009 93
A R T I C L E(Wilkinson et al., 1989) in a number of sites including the seg-
mented hindbrain (Swiatek and Gridley, 1993; Voiculescu et
al., 2001).
Krox20, also known as early growth response 2 (Egr2), be-
longs to the zinc finger-encoding, egr family of genes whose
transcription is rapidly activated by extracellular stimuli in the
absence of de novo protein synthesis. EGR proteins relay ex-
tracellular signals and elicit long-term intracellular responses
by regulating the transcription of their target genes through
specific binding to a GC-rich region (Swirnoff and Milbrandt,
1995). EGR proteins play important roles in cellular growth and
differentiation and responses to hormonal stimuli (Lee et al.,
1996; Swiatek and Gridley, 1993; Schneider-Maunoury et al.,
1993; Topilko et al., 1994; Tourtellotte and Milbrandt, 1998).
For example, Egr1, also known as Krox24, has been identified
as the transcription activator of low-density lipoprotein recep-
tor in response to oncostatin M stimulation (Zhang et al., 2002).
It has also been established that Krox20 expression is essential
for the final differentiation of myelinating Schwann cells (Zorick
et al., 1996; Warner et al., 1998). However, a role of Krox20 in
the fat cell development has not been previously explored.
The aim of these studies was to investigate whether Krox20
played a role in the process of adipocyte differentiation and to
further provide insights into its mechanism. Our findings have
uncovered an essential, stimulatory role of Krox20 in adipogen-
esis in vitro partially through and in cooperation with C/EBPβ.
Results
Krox20 is an immediate-early gene
during 3T3-L1 adipogenesis
We have previously shown that Krox20 is highly enriched in the
white adipose tissue in vivo but not readily detectable in fully
differentiated adipocytes cultured from 3T3-L1 cells in vitro.
However, because Krox20 has been shown to be transiently
upregulated in naive NIH3T3 cell fibroblasts by serum stimula-
tion, we performed a detailed time course of Krox20 expres-
sion during adipocyte development from 3T3-L1 cells in vitro,
focusing on analyses at earlier time points than were analyzed
in our previously published survey. 3T3-L1 cells were induced
to differentiate into adipocytes by treating confluent cells with
a standardized hormonal cocktail as previously described.
Quantitative RT-PCR (Taqman assay) of Krox20 as well as a
group of other adipocyte marker genes revealed that Krox20
mRNA was first induced at 15 min after exposure to the induc-
tion cocktail and peaked around 1 hr postinduction. Krox20
mRNA was quickly diminished after this and became undetect-
able at 6 hr and thereafter (see Figure S1 in the supplemental
data available with this article online). The kinetics of Krox20
induction was similar to that of C/EBPβ and was expressed
earlier than C/EBPα and PPARγ, two established inducers of
adipocyte differentiation, suggesting that it might play an early
role in the process of adipogenesis.
Ectopic expression of Krox20 promotes adipogenesis
We next tested whether a gain of Krox20 can promote adipo-
cyte differentiation by examining the effect of constitutive ex-
pression of Krox20 in 3T3-L1 preadipocytes. Cell lines stably
expressing a HA-tagged Krox20 or a vector-HA control were
established by retroviral transduction followed by puromycin
selection. A PPARγ cell line was also established for compari-94son. In this and all subsequent experiments, at least 30% or
more of the cell population was transduced by individual re-
combinant retroviruses. The virally transduced nonclonal pop-
ulation of puromycin resistant cells was expanded, cultured to
confluence, and harvested for Western blot analysis to confirm
expression of the virally expressed gene.
In the cells infected with the Krox20-expressing retrovirus, a
unique 48 kDa band was detected, while, in the PPARγ-line,
the 60 kDa PPARγ protein was detected. Neither protein was
detectable in the control line (Figure 1A). RT-PCR was also
used to confirm the presence of viral transcripts (data not
shown). Each of the transduced cell lines was then induced to
differentiate until day 7. Oil Red O (ORO) staining of the dishes
at different time points demonstrated that Krox20-overexpress-
ing cells began to accumulate lipid earlier than control cells. In
addition, after 7 days, a higher percentage (around 90%) of fat-
laden cells was evident, as compared to the control cell line
(up to 70%). The fat droplets in differentiated cells in the
Krox20 line also appeared larger. The differentiation of the
PPARγ cells was even more robust, with nearly all of the preadi-
pocytes developing into adipocytes with large fat droplets (Fig-
ure 1B). Consistent with these morphological observations,
Krox20 enhanced the expression of aP2, adipsin, and PPARγ,
marker genes for adipogenesis, with a significantly higher level
of expression and with a faster kinetics than in the control cell
line (Figure 1C). These data indicate that, as assessed by both
morphologic and molecular criteria, overexpression of Krox20
stimulates adipogenesis in 3T3-L1 preadipocytes.
Krox20 can commit the multipotent NIH3T3
cells to an adipogenic fate
The high level of expression of Krox20 in vivo suggested that
it might also be able to stimulate differentiation in NIH3T3 cells,
a line with very little adipogenic potential. To test this, NIH3T3
cells were infected with retroviruses carrying either Krox20-HA,
vector-HA, or PPARγ; selected with puromycin; and expanded.
Western blotting was performed to analyze expression of the
transduced gene in each cell line (Figure 2A). All cells were
cultured to confluence and then exposed to a similar cocktail
as used with 3T3-L1 cells (5 g/ml insulin, 1 g/ml dexametha-
sone, 0.5 mM IBMX). At day 7 postinduction, lipid-containing
cells were not detected in the vector control cells, whereas a
significant fraction of the NIH-PPARγ and NIH-Krox20 cells
(around 70% and 20%, respectively) differentiated into fat-
laden cells with the typical morphology of cultured adipocytes.
The addition of the PPARγ ligand, troglitazone, further enhanced
adipose conversion in the NIH-PPARγ and NIH-Krox20-HA cells,
again with no evident changes in the control cells (Figure 2B).
The RNA levels for adipocyte marker genes (aP2, adipsin,
PPARγ) were extremely low at day 7 after exposure to the in-
duction cocktail in the control line. In comparison, these adipo-
cyte marker genes were all significantly induced in the NIH-
Krox20 cells to levels w30%–40% relative to NIH-PPARγ cells
(Figure 2C) This result demonstrated that expression of Krox20,
like PPARγ, is sufficient to convert naive NIH3T3 fibroblasts into
differentiated adipocytes, an effect that has been only seen
previously with C/EBPs and PPARγ (Yeh et al., 1995; Tontonoz
et al., 1994).CELL METABOLISM : FEBRUARY 2005
Krox20 is an early key factor in adipogenesisFigure 1. Krox20 promotes adipogenesis in the 3T3-L1 preadipocyte
3T3-L1 cells were infected with recombinant retroviruses derived from pMSCVpuro-HA, pMSCVpuro-Krox20-HA, or pMSCVpuro-PPARγ; selected; and induced for
differentiation till day 7.
A) Total protein lysates were harvested at confluence for Western blot analysis showing the overexpressed Krox-HA or PPARγ proteins. Equal amounts of total lysates
were blotted with anti-β-actin as a control.
B) ORO staining of individual cell lines at days 3, 5, or 7 showing fat development.
C) Taqman assay was performed to analyze the mRNA levels of aP2, adipsin, and PPARγ at different time points postinduction as indicated.CELL METABOLISM : FEBRUARY 2005 95
A R T I C L EFigure 2. Krox20 induces adipogenesis in the naive NIH3T3 cells
NIH3T3 cells were infected with recombinant retroviruses derived from pMSCVpuro-HA, pMSCVpuro-Krox20-HA, or pMSCVpuro-PPARγ; selected; and induced for
differentiation with a hormonal cocktail with or without troglitazone until day 7.
A) Western blot analysis of the cells at confluence showing ectopic expression of Krox-HA or PPARγ. Equal amounts of total lysates were blotted with anti-β-actin as
a control.
B) (Top panel) A macroscopic view of the ORO-stained dishes on day 7. (Bottom panel) A microscopic view. Scale bars, 100 M.
C) Taqman assay was performed to analyze the mRNA levels of aP2, adipsin, and PPARγ at day 7.96 CELL METABOLISM : FEBRUARY 2005
Krox20 is an early key factor in adipogenesisKrox20 gene silencing using siRNA results
in impaired adipogenesis
To determine whether Krox20 is necessary for adipogenesis, we
next used retroviruses carrying small interfering RNA (siRNA) for
Krox20 to knock down its expression. Two independent hairpin
siRNA oligonucleotide sequences from Krox20 were selected
and cloned into the pSIREN-RetroQ retroviral plasmid. The re-
combinant plasmids were transfected into the Phoenix pack-
aging cells to produce retroviruses that carry both the siRNA
hairpin and the puromycin resistance gene. A negative control
oligonucleotide was processed in a similar manner.
3T3-L1 cells were infected with the hairpin-containing viruses,
selected, and established as a stable cell line with constitutive
siRNA expression. Cells were cultured to confluence and ex-
posed to the standard differentiation cocktail. Total RNA at dif-
ferent time points during the early time window was collected,
and the mRNA level of Krox20 and other genes was determined
by Taqman assay. At 30 min postinduction, the si-Krox20-a and
si-Krox20-b lines showed slightly lower levels of Krox20 ex-
pression than the control line; at 1 hr, a time when Krox20
mRNA expression is maximal, the si-Krox20-a and si-Krox20-b
lines displayed less than 30% of the expression level of the
control line. These data showed that two different siRNA hair-
pins resulted in an efficient knockdown of Krox20 (Figure 3A).
The cell lines were then cultured in the presence of the differ-
entiation cocktail for 8 days. ORO staining of the dishes at days
4 and 8 demonstrated that the si-Krox20-a and si-Krox20-b lines
accumulated significantly less lipid than the control line (Figure
3B). Measurement of the adipocyte gene RNA levels by Taqman
assay confirmed that the differentiation process in the si-Krox20-a
and si-Krox20-b lines was suboptimal and much less robust
than the control line (Figure 3C). At day 8, the RNA levels of
aP2, PPARγ, and adipsin in the si-Krox20-a or -b lines were
reduced to 30%–50% of those in control cells. However, the si-
Krox20-a and si-Krox20-b siRNAs did not completely abrogate
adipogenesis, perhaps due to the residual level of Krox20 ex-
pression. These results establish that Krox20 is necessary for
normal differentiation of 3T3-L1 cells.
Systematic deprivation of hormonal components
compromises the ability of Krox20
to promote adipogenesis
We next tested whether Krox20 can obviate the need for some
or all of the complement of hormones necessary for the induc-
tion of adipogenesis. For example, PPARγ (but no other factors)
can fully induce adipocyte differentiation in the absence of
these hormonal factors. Krox20, PPARγ, and control cell lines
were established as described and confirmed to express the
virally transduced genes (Figure 4A). Cells were grown to con-
fluence and treated with an adipogenic cocktail in which dif-
ferent components were systematically omitted. A separate
condition using a PPARγ ligand (troglitazone) alone was in-
cluded. The cells were then cultured for 7 days when ORO
staining was performed (Figure 4B). Full differentiation was ob-
served for all cell lines when insulin (INS), dexamethasone
(DEX), and IBMX were all included (condition A). When INS was
omitted (condition B), there was a modestly decreased fat
content in each cell line, but Krox20 still exerted a significant
inductive effect. This indicates that INS is dispensable for
Krox20’s promoting effect. In contrast, when either DEX or
IMBX was removed (conditions C and D, respectively), fat ac-CELL METABOLISM : FEBRUARY 2005cumulation was markedly reduced in the Krox20 and the con-
trol lines. In contrast, there was still considerably more lipid
accumulation in the PPARγ line than in the control line, even
without DEX or IMBX. Thus, the promoting effect of Krox20
was dependant on DEX and/or IBMX, which are known induc-
ers of C/EBPδ and C/EBPβ, respectively (Cao et al., 1991). Fi-
nally, the Krox20 line did not accumulate appreciably more lipid
than the control line when troglitazone was added alone (con-
dition E) or in the presence of standard culture media without
INS, DEX, or IBMX (condition F). Taqman assay was performed
to examine the mRNA levels of aP2, adipsin, and PPARγ at
either day 0 or day 7 under these various conditions (A–F), and
the results were consistent with the morphologic changes (Fig-
ure 4C). Taken together, these data suggest that the adipogen-
esis-promoting effect of Krox20 is dependent on the presence
of DEX and IBMX.
Ectopic expression of Krox20 leads to an induction
of C/EBPβ expression and transactivation
of C/EBPβ promoter
Krox20 and C/EBPβ are expressed with similar kinetics, and
both promote adipogenesis, suggesting that they might both
be elements of a differentiation pathway that regulates early
cellular programs that promote adipogenesis. To further ad-
dress this possibility, we first compared the expression level of
C/EBPβ in 3T3-L1-Krox20-HA cells with that of the 3T3-L1-HA
control cells. Total RNA of these two cell lines was collected at
different time points in the early window postinduction under
conditions A–D as described above (see Figure 4). When cells
were exposed to a full complement of hormones (condition A),
C/EBPβ mRNA was increased w3 fold in Krox20-expressing
cells as compared to the control line. C/EBPβ was still induced
w2 fold in the Krox20 cells when insulin was omitted (condition
B). When either DEX or IBMX was deprived (conditions C or D),
there was only marginal increase in C/EBPβ mRNA in Krox20-
expressing cells as compared to the control line (Figure 5A).
We further harvested total protein lysates of each cell line
under various conditions at day 2 postconfluence and per-
formed Western blotting to examine C/EBPβ protein levels. In
conditions A and B, signal was much stronger for C/EBPβ in
the Krox20 cells than in the control cells, whereas, in condi-
tions C and D, increase in C/EBPβ protein expression was
barely detected (Figure 5B). These data indicate that ectopic
expression of Krox20 leads to an induction of C/EBPβ mRNA
and protein in a DEX- and IBMX- dependent fashion.
The above results prompted us to further investigate whether
Krox20 would transactivate C/EBPβ promoter. For this pur-
pose, the pMSCVpuro-Krox20-HA or the control pMSCVpuro-
HA plasmids were cotransfected with a C/EBPβ promoter lucif-
erase reporter plasmid (B3K) (generously provided by Dan
Lane) into 3T3-L1 cells at 80% confluence (Zhang et al., 2004).
The empty reporter vector (BA) was included as a control. At
day 2 postconfluence, cells were treated with the differentiation
cocktail or media alone. Protein lysates were harvested, and
luciferase assays were performed 12 hr later (Figure 5C). Co-
transfection of Krox20 transactivated the C/EBPβ promoter
(B3K) 3-fold to that seen with the control pMSCVpuro-HA plas-
mid; omission of the hormonal cocktail abrogated this effect,
suggesting that transactivation of C/EBPβ by Krox20 is depen-
dent on hormonal inducers.97
A R T I C L EFigure 3. Effect of siRNA knockdown of Krox20 on 3T3-L1 adipogenesis
3T3-L1 cells were infected with pSIREN-RetroQ-derived retroviruses carrying either siRNA oligos for Krox20 (si-Krox20-a or -b) or control oligo, selected for puromycin
resistance, and expanded. Cells were then induced by regular hormonal cocktail to differentiate till day 8.
A) Taqman assay was performed to analyze the expression level of Krox20 at different time points, as indicated in the earliest window of induction.
B) ORO staining of individual dishes at day 4 or day 8 showing fat development.
C) Taqman assay showing expression levels of aP2, adipsin, and PPARγ at different time points during differentiation.98 CELL METABOLISM : FEBRUARY 2005
Krox20 is an early key factor in adipogenesisFigure 4. The adipogenesis-promoting effect of Krox20 is reduced by systematic deprivation of normal hormonal stimulants
Stable 3T3-L1 cell lines that were transduced with Krox20-HA, PPARγ, or control were established as in Figure 2 and induced for differentiation with hormonal cocktails
as indicated till day 7.
A) Western blot analyses of the cells at confluence showing ectopic expression of Krox20 or PPARγ proteins. Equal amounts of total lysates were blotted with anti-β-
actin as a control.
B) ORO staining of individual dishes at day 7 showing fat development.
C) Taqman assay was performed to analyze the mRNA levels of aP2, adipsin, and PPARγ under different conditions at days 0 (confluence) or 7.CELL METABOLISM : FEBRUARY 2005 99
A R T I C L EFigure 5. Ectopic expression of Krox20 enhances
C/EBPβ expression and transactivates the C/EBPβ
promoter
A) The 3T3-L1-Krox20-HA or control cell lines from
Figure 4 were induced to differentiate under condi-
tions A–D as described in Figure 4. Total RNA was
harvested at different time points postinduction as
indicated. Taqman assay was carried out to mea-
sure the C/EBPβ mRNA level.
B) Protein lysates for both cell lines under all four
conditions were collected at 2 days postinduction
for anti-C/EBPβ Western blot (upper panel); anti-β-
actin blot was included as control (lower panel).
C) pMSCVpuro-Krox20-HA or pMSCVpuro-HA was
cotransfected into 3T3-L1 preadipocytes with indi-
vidual reporters as denoted, along with the pRL-TK
as an internal control. Cells were induced to dif-
ferentiate 2 days later. Total proteins were harvested
at 12 hr postinduction and dual luciferase activities
determined. The value of firefly luciferase was nor-
malized by the rennila luciferase to generate the rel-
ative luciferase activity; error bars represent the
standard deviation of three independent experi-
ments.Krox20 exerts its adipogenic effect at least in part
through activating C/EBPβ
The above results suggested that Krox20 might promote adi-
pogenesis by activating C/EBPβ. We therefore examined whether
reduced expression of C/EBPβ by siRNA would compromise
the inductive effect of Krox20 on adipogenesis in 3T3-L1 cells.
3T3-L1 cells were coinfected with either of two different puro-
mycin resistance-carrying retroviruses that deliver hairpin100oligos targeting C/EBPβ (si-C/EBPβ-a and si-C/EBPβ-b), to-
gether with a hygromycin resistance-carrying retrovirus that
encodes Krox20-HA. Control lines were also established. All
lines were induced for 7 days. At day 2, protein lysates were
harvested, and the level of virally expressed Krox20 (Figure 6A,
middle panel) and endogenous C/EBPβ proteins were deter-
mined by Western blotting (Figure 6A, upper panel).
In the control lines (Figure 6A, lanes 1–3) and Krox20-overex-CELL METABOLISM : FEBRUARY 2005
Krox20 is an early key factor in adipogenesisFigure 6. siRNA knockdown of C/EBPβ partially impairs the promoting effect of Krox20
3T3-L1 cells were coinfected with pMSCVhyg-derived retroviruses carrying either Krox20-HA or control insert and pSIREN-RetroQ-derived retroviruses carrying either
siRNA oligos for C/EBPβ (si-C/EBPβ-a and -b) or control oligo, selected for hygromycin and puromycin resistance, and induced to differentiate till day 7.
A) Western blot analysis of individual cell lines at day 2 showing endogenous level of C/EBPβ (top panel) and the ectopically expressed Krox20 (middle panel). Anti-β-
actin blot was included as control (bottom panel).
B) ORO staining of individual dishes at day 7 showing fat development.
C) Taqman assay of the expression level of aP2, adipsin, and PPARγ of different cell lines at time points indicated.pressing lines (Figure 6A, lanes 4–6), delivery of specific hair-
pins resulted in a significant reduction of C/EBPβ by at least
70% compared to the negative control oligo, demonstrating an
efficient knockdown of C/EBPβ by both the si-C/EBPβ-a and
si-C/EBPβ-b hairpins. ORO staining of control cell lines on dayCELL METABOLISM : FEBRUARY 20057 showed that delivery of either si-C/EBPβ-a or si-C/EBPβ-b
resulted in a significant reduction of fat content (Figure 6B, up-
per dishes). This is consistent with earlier reports that a loss of
C/EBPβ function reduces adipogenesis in vivo and in vitro
(Hamm et al., 2001; Tanaka et al., 1997). Delivery of either hair-101
A R T I C L Epin into the Krox20-overexpressing cells also significantly re-
duced fat accumulation (Figure 6B, bottom dishes), showing
that knockdown of C/EBPβ reduced the proadipogenic effect
of Krox20. However, Krox20 overexpression in the si-C/EBPβ-a
or si-C/EBPβ-b lines still exhibited more fat accumulation than
control cells (Figure 6B, comparing upper dishes and bottom
dishes in lanes 1 and 2). The effect of the C/EBPβ knockdown
was evaluated by Taqman assay of aP2, adipsin, and PPARγ
RNA levels at confluence, day 2, and day 7 (Figure 6C). These
studies showed that the si-C/EBPβ-a or si-C/EBPβ-b hairpins
reduce but do not fully block the ability of Krox20 to induce
adipocyte marker genes. These data suggest that Krox20 acts
in part by activating C/EBPβ, but it might also exert its proadi-
pogenic effects independent of C/EBPβ.
Krox20 cooperates with C/EBPβ in inducing
adipogenesis in NIH3T3 cells
If Krox20 has inductive effects on adipogenesis that are inde-
pendent of C/EBPβ, we predicted that cotransfection of both
genes would have an additive effect even in undifferentiated
3T3 cells. To test this, naive NIH3T3 cells were infected with
retroviruses carrying Krox20-HA, C/EBPβ, or both genes. Con-
trol infections with empty vectors were included. Cells were
selected, expanded, and induced to differentiate for 7 days.
Protein assays using Western blots confirmed the overexpres-
sion of C/EBPβ and Krox20 in the virally infected cells (Figure
7A). ORO staining on day 7 indicated that Krox20 and C/EBPβ
overexpression could induce adipogenesis in some but not all
of the cells.
In contrast, when Krox20 and C/EBPβ were coexpressed, all
cells became fully differentiated adipocytes, with a substan-
tially greater amount of lipid accumulation in each cell (Figure
7B). This inductive effect was indistinguishable from that seen
with PPARγ (as shown in Figure 3). Assays of the mRNA levels
confirmed that cells infected with both the Krox20 and C/EBPβ
viruses had higher levels of aP2, adipsin, and PPARγ than either
gene alone (Figure 7C), further demonstrating that these two
genes have a synergistic effect on adipogenesis in NIH3T3 cells.
Discussion
Cell specification in mammals is a multistep process in which
cells first become determined or committed to a develop-
mental fate, after which they differentiate and acquire the prop-
erties of a specific cell type. Adipocyte development is con-
trolled by a series of steps that lead fibroblasts to become
preadipocytes. When further induced, preadipocytes differenti-
ate and express genes that allow them to store lipid and carry
numerous other regulatory functions performed by mature adi-
pocytes. While many of the components of the gene regulatory
network that controls the differentiation of adipocytes have
been elucidated in studies of cultured 3T3-L1 and 3T3-F442
preadipocytes, recent evidence has suggested that additional
factors are likely to be necessary in vivo (Soukas et al., 2001).
To identify such factors, we have studied the functions of a
number of transcription factors that are enriched in adipose
tissue in vivo. The results presented here identify Krox20 as
playing a key role in the process of adipogenesis and charac-
terize it as one of the small group of factors capable of induc-
ing uncommitted fibroblasts to become adipocytes. It has been
well established that PPARγ is the really dominant regulator,102and, in cultured cells, C/EBPβ plays a key role in elevating it.
However, what drives C/EBPβ has been an important unan-
swered question. Our studies identify Krox20 as an important
early regulator that controls C/EBPβ level and complements
C/EBPβ in inducing PPARγ and the full program of adipo-
genesis.
Krox20 overexpression leads to upregulation of PPARγ gene
expression and augments morphologic differentiation of 3T3-
L1. siRNA-mediated reduction of Krox20 level reduces the RNA
levels of PPARγ and impairs 3T3-L1 adipogenesis, indicating
that Krox20 is required in this process. During adipogenesis,
PPARγ functions as a “switch” that regulates whether or not
preadipocytes differentiate into adipocytes (Rosen et al., 1999,
2002). These results suggest that Krox20 is an important com-
ponent of the transcription factor network controlling whether
or not PPARγ is expressed in sufficient quantities to fully induce
adipocyte differentiation.
These effects of Krox20 are mediated in part by induction of
C/EBPβ gene expression. C/EBPβ has been shown previously
to be among the first transcription factors activated during adi-
pogenesis. Krox20 gene expression is also induced early dur-
ing adipogenesis in response to INS, DEX, and IBMX, with sim-
ilar kinetics to C/EBPβ. Increased Krox20 expression results
in upregulation of C/EBPβ gene expression, and Krox20 can
transactivate the C/EBPβ promoter, suggesting that Krox20’s
positive effect on adipocyte differentiation may be mediated at
least in part by transactivation of C/EBPβ. This conclusion is
further supported by the reduction in differentiation of cells
overexpressing Krox20 when C/EBPβ levels are knocked down
by RNAi. However, these studies do not establish whether the
effects of Krox20 on C/EBPβ gene expression are direct or in-
direct. In preliminary studies, Krox20 was able to transactivate
a C/EBPβ promoter luciferase reporter construct (Figure 5), and
a deletion series further localized the response element to be-
tween −1438 and −1134 base pairs (data not shown). The abil-
ity of Krox20 to activate the C/EBPβ promoter depended on
the presence of the standard hormonal differentiation cocktail,
as was also the case with Krox20’s inductive effect on adipo-
genesis. However, the 3 kb proximal promoter of C/EBPβ does
not contain a consensus Krox20 response element (T-G-C-G-
T/g-G/A-G-G-C/a/t-G-G/T) (Swirnoff and Milbrandt, 1995). In
addition, C/EBPβ promoter sequences were not detected in
chromatin immunoprecipitation assays after precipitation of
Krox20 (data not shown), suggesting that Krox20 activates
C/EBPβ gene expression indirectly. In this regard, the purifica-
tion of the factor(s) binding to C/EBPβ promoter sequences
between −1438 and −1134 may lead to the elucidation of the
cellular pathways responsible for the activation of C/EBPβ dur-
ing adipogenesis.
The residual adipocyte phenotype in the cells expressing
Krox20 and the C/EBPβ siRNA suggests that Krox20 also ex-
erts its effect via C/EBPβ-independent pathways. This possi-
bility is further supported by the observation that Krox20 and
C/EBPβ have synergistic effect on the differentiation of naive
3T3 cells. Indeed, the expression of both factors together re-
sults in a fully induced adipocyte phenotype in NIH3T3 cells
similar to that seen after expression of PPARγ. This effect is
not evident with any other transcription factors. Taken together,
these observations suggest that Krox20 plays an early role, in-
deed the earliest known role, in fat cell development.
The C/EBPβ-independent mechanism by which Krox20 stim-CELL METABOLISM : FEBRUARY 2005
Krox20 is an early key factor in adipogenesisFigure 7. Krox20 and C/EBPβ cooperate in stimulating adipogenesis in the naive NIH3T3 cells
NIH3T3 cells were coinfected with pMSCVpuro-derived retroviruses carrying either C/EBPβ or empty vector and pMSCVhyg-derived retroviruses carrying either Krox20-
HA or HA epitope alone, selected for hygromycin and puromycin resistance, and expanded. Cells were then induced to differentiate by 5 g/ml insulin, 1 g/ml
dexamethasone, and 0.5 mM IBMX and cultured until day 7.
A) Western blot analysis of individual cell lines at confluence showing ectopically expressed C/EBPβ (top panel) or Krox20 (middle panel). Anti-β-actin blot was included
as control (bottom panel).
B) ORO staining of individual cell lines at day 7 showing fat development (upper, macroscopic view; lower, microscopic view). Scale bars, 100 M.
C) Taqman assay of the expression level of aP2, adipsin, and PPARγ of different cell lines at time points indicated.CELL METABOLISM : FEBRUARY 2005 103
A R T I C L Eulates adipogenesis is not known. Our observation that PPARγ
ligands do not amplify the effects of Krox20 suggest that
PPARγ is unlikely to be the direct transcriptional target of
Krox20. In this case, Krox20 may activate PPARγ indirectly via
C/EBPβ, which is a known activator for PPARγ (Tang et al.,
2004). The fact that Krox20 has effects independent of C/EBPβ
makes it important to identify its other targets. It is known that,
in brain, Krox20 regulates segmentation of the central nervous
system with its direct downstream targets there including some
homeobox genes (Chavrier et al., 1990; Sham et al., 1993). Re-
cent results have suggested that some members of the ho-
meobox gene family may also play an important role in adipo-
genesis (Cowherd et al., 1997). Whether these homeobox
genes are additional downstream mediators of Krox20’s action
in response to hormonal induction needs to be explored. Com-
paring the transcriptional profiles of Krox20- and C/EBPβ-over-
expressing cells may help identify additional Krox20 target
genes in fat cells.
The proadipogeneic effects of Krox20 as well as its ability
to induce C/EBPβ are both dependent on the addition of the
standard inducers of adipogenesis (i.e., insulin, IBMX, and dex-
amethasone). This suggests that Krox20 interacts with other
factors to activate C/EBPβ and promote adipogenesis. Further
studies may reveal the identity of these other factors, including,
perhaps, recently reported positive regulators such as O/E1
(Akerblad et al., 2002), E2F1 (Fajas et al., 2002), and Notch1
(Garces et al., 1997). Recent studies also implicated a panel of
negative regulators, including Pref1 (Lee et al., 2003; Moon et
al., 2002), Wnt10b (Longo et al., 2004), Foxa-2 (Wolfrum et al.,
2003), Foxo1 (Nakae et al., 2003), GATA-2 and -3 (Tong et al.,
2000), and E2F4 (Fajas et al., 2002; Landsberg et al., 2003), in
the process of adipogenesis. At present, however, the func-
tional relationship between Krox20 and these signaling mole-
cules is not known.
The function of Krox20 during adipogenesis in vivo has not
yet been established and is under investigation. In addition to
its expression during adipocyte differentiation, Krox20 is also
expressed in brain, adipose tissue, and other tissues in adult
mice. Krox20 knockout mice die perinatally, apparently as a
result of abnormalities in brain development (Swiatek and Grid-
ley, 1993). The possible requirement for Krox20 in adipocyte
development in vivo will thus await studies of mice with an
adipocyte-specific knockout.
Little is known about the developmental signals that control
the development of adipocytes in vivo. Krox20 is expressed at
high levels in vivo but is only expressed transiently in cultured
cells, suggesting that it may play a role in initiating and/or
maintaining adipogenesis in vivo. In adipose tissue, Krox20 is
expressed in a stromal cell/preadipocyte function, and it could
play a role in the development or maintenance of these cells
from precursor cells. Krox20 is also expressed in adipocytes,
where it could also play a role in regulating transcriptional pro-
grams for genes that are enriched in vivo (Soukas et al., 2001).
Further studies of the transcriptional targets of Krox20 will help
elucidate this possibility. While Krox20 can be induced by se-
rum in naive 3T3 fibroblasts, the mechanism responsible for its
induction in vivo is unknown. If, as suggested by data in this
report, Krox20 is a marker for early events of adipogenesis, the
dissection of the mechanisms controlling its expression could
lead in turn to the identification of the signals that control adi-
pogenesis in vivo.104In summary, we report the identification of Krox20 as playing
an essential role in adipocyte differentiation. These findings
place Krox20 in a group of key proadipogenic transcription
factors, including PPARγ, C/EBPs, and SREBP1 (Kim and Spie-
gelman, 1996; Kim et al., 1998), and further identify it as the
earliest inductive factor expressed during adipogenesis. Be-
cause Krox20 was identified in a screen for transcription factors
that are enriched in adipose tissue in vivo, an analysis of its
regulation in vivo could lead to a fuller understanding of regula-
tion of adipogenesis in vivo.
Experimental procedures
Retroviral plasmids and infections
The GenBank accession numbers for the Krox20 and C/EBPβ sequences
reported in this paper are X06746 and X62600, respectively. Krox20 was
cloned by RT-PCR and modified to have a fusion of HA epitope at the C
terminus. It was subsequently inserted into pMSCVpuro or pMSCVhyg
(Clontech). The control pMSCVpuro-HA and pMSCVhyg-HA were also con-
structed. The pMSCV-PPARγ2 plasmid was as described earlier (Rosen et al.,
2002). C/EBPβ was also cloned by RT-PCR and inserted into pMSCVpuro.
For knockdown of Krox20 or C/EBPβ expression in 3T3-L1 cells, the
DNA-based, retroviral vector-mediated siRNA technology was used. The
targeted sequence was determined by the Whitehead Institute siRNA
designing tool and verified by BLAST searches to ensure specificity. Two
complementary oligos for each targeted sequence were then designed ac-
cording to the protocol of Clontech’s RNAi-Ready pSIREN-RetroQ system,
annealed, and ligated into the BamHI/EcoRI-linearized pSIREN-RetroQ vec-
tor. The resulted plasmid, upon packaged into retrovirus, allowed stable
expression of siRNA hairpin for a specific gene. Sequences for the oligonu-
cleotides cloned into pSIREN-RetroQ were as follows: si-C/EBPβ-a-top, 5#-
GATCCGAGATGTTCCTGCGGGGTTGTTCAAGAGACAACCCCGCAGGAAC
ATCTCTTTTTTGCTAGCG; si-C/EBPβ-a-bottom, 5#-AATTCGCTAGCAAAA
AAGAGATGTTCCTGCGGGGTTGTCTCTTGAACAACCCCGCAGGAACATC
TCG; si-C/EBPβ-b-top, 5#-GATCCGGCTGAGCGACGAGTACAAGTTCAAG
AGACTTGTACTCGTCGCTCAGCCTTTTTTGCTAGCG; si-C/EBPβ-b-bottom,
5#-AATTCGCTAGCAAAAAAGGCTGAGCGACGAGTACAAGTCTCTTGAAC
TTGTACTCGTCGCTCAGCCG; si-Krox20-a-top, 5#-GATCCGTGTCACTGC
CGCTGATTTGTTCAAGAGACAAATCAGCGGCAGTGACACTTTTTTGCTA
GCG; si-Krox20-a-bottom, 5#-AATTCGCTAGCAAAAAAGTGTCACTGCCG
CTGATTTGTCTCTTGAACAAATCAGCGGCAGTGACACG; si-Krox20-b-top,
5#-GATCCGGCTCTGGCTGACACACCAGTTCAAGAGACTGGTGTGTCAG
CCAGAGCCTTTTTTGCTAGCG; si-Krox20-b-bottom, 5#-AATTCGCTAGCA
AAAAAGGCTCTGGCTGACACACCAGTCTCTTGAACTGGTGTGTCAGCC
AGAGCCG; negative control top, 5#-GATCCGTGCGCTGCTGGTGCCAA
CTTCAAGAGATTTTTTGCTAGCG; and negative control bottom, 5#-AATTC
GCTAGCAAAAAATCTCTTGAAGTTGGTACTAGCAACGCACG. All plasmids
were verified by sequencing.
Recombinant pMSCV or pSIREN-RetroQ viral packaging was achieved
by transfection of the plasmid into Phoenix ecotropic packaging cells (cul-
tured in DMEM with 10% FBS in 5% CO2) using Lipofectamine 2000 (Invit-
rogen) (Pear et al., 1993). Viral supernatants were supplemented with 8
g/ml polybrene and added to cells for infections for 24–36 hr. Cells were
selected with 2 g/ml puromycin or 100 g/ml hygromycin (Sigma), ex-
panded, and seeded for differentiation experiments.
Adipocyte differentiation assays
3T3-L1 cells (ATCC) were maintained in DMEM with 10% FBS (Invitrogen)
in 5% CO2. Stable cell lines from retroviral transduction were cultured to
confluence and exposed to the differentiation cocktail (1 g/ml insulin, 0.25
g/ml dexamethasone, 0.5 mM IBMX). After 48 hr, cells were maintained in
medium containing 1 g/ml insulin until day 7 for harvest. NIH3T3 was as
described in Brun et al. (1996) and cultured in DMEM with 10% calf serum
(Invitrogen) in 5% CO2. Stably transduced NIH3T3 was differentiated by 5
g/ml insulin, 1 g/ml dexamethasone, 0.5 mM IBMX for 48 hr and then
cultured in the maintenance media with 5 g/ml insulin untill day 7 for har-
vest. Troglitazone (Calbiochem) was used at 10 M wherever indicated.
ORO staining was performed as described earlier (Soukas et al., 2001).CELL METABOLISM : FEBRUARY 2005
Krox20 is an early key factor in adipogenesisRT-PCR and Western blot analyses
Total RNA was isolated from cells by TRIZOL reagent (Invitrogen).
Quantitative RT-PCR was performed by the Taqman system (Applied Bio-
systems) according to the manufacturer’s instructions. Oligos were de-
signed by the PrimerExpress software. Threshold cycles (Ct) for the internal
control (cyclophilin) and target genes were determined from raw fluores-
cence. The amount of each gene was derived from its Ct and normalized
with the amount of cyclophilin. Samples are in duplicate.
Sequences of the Taqman primers and probes are the following: cyclophilin-
F, 5# TGTGCCAGGGTGGTGACTT; cyclophilin-R, 5#-TCAAATTTCTCTCCG
TAGATGGACTT; cyclophilin-probe, 5#-ACACGCCATAATGGCACTGGTGG;
aP2-F, 5#-CACCGCAGACGACAGGAAG; aP2-R, 5#-GCACCTGCACCAGGGC;
aP2-probe, 5#-CCGCCATCTAGGGTTATGATGCTCTTCA; PPARγ-F, 5#-CCATT
CTGGCCCACCAAC; PPARγ-R, 5#-AATGCGAGTGGTCTTCCATCA; PPARγ-
probe, 5#-TCGGAATCAGCTCTGTGGACCTCTCC; Krox20-F, 5#-GCAAAGGA
CCTTGATGGAGC; Krox20-R, 5#-GGCCTAAGTTTTCGGAAGGC; Krox20-
probe, 5#-CAGCTCTGTCCCACCTTCTCACGGAC; C/EBPα-F, 5#-TCTGCG
AGCACGAGACGTC; C/EBPα-R, 5#-AACTCGTCGTTGAAGGCGG; C/EBPα-
probe, 5#-AGACATCAGCGCCTACATCGACCCG; C/EBPβ-F, 5#-CTATTTCTAT
GAGAAAAGAGGCGTATGTAT; C/EBPβ-R, 5#-ATTCTCCCAAAAAAGTTTATT
AAAATGTCT; C/EBPβ-probe, 5#-TTTGAGAACCTTTTCCGTTTCGAGCATTA
AAGT; C/EBPδ-F, 5#-TGCCCACCCTAGAGCTGTG; C/EBPδ-R, 5#-CGCTTT
GTGGTTGCTGTTGA; C/EBPδ-probe, 5#-CACGACGAACTCTTCGCCGAC
CTC; adipsin-F, 5#-CGAAGGTGTGGTTACGTGGG; adipsin-R, 5#-GGGTAT
AGACGCCCGGCTT; adipsin-probe, 5#-TGCCATTGCCACAGACGCGAGA.
Whole-cell protein lysates were prepared, and Western blot analyses
were performed as described (Chen and Cobb, 2001). Total protein (20–50
g) was loaded on SDS-PAGE for each sample. Rabbit anti-HA, rabbit anti-C/
EBPβ, and mouse anti-PPARγ were from Santa Cruz (Y-11, C-19, and E-8,
respectively). Anti-mouse β-actin was from Sigma. HRP-conjugated anti-
rabbit and anti-mouse secondary antibodies were from Jackson laboratory.
Transfection and reporter assays
The empty control luciferase reporter pGL3-BA is a Promega product. The
3000 base pair C/EBPβ promoter was inserted into pGL3-BA to generate
the C/EBPβ reporter (B3K), as described earlier (Zhang et al., 2004). These
plasmids were kindly provided by Daniel Lane. The reporter plasmid was
transfected using Lipofectamine and the PLUS reagent (Invitrogen) into
3T3-L1 cells at 80% confluence in combination with either pMSCVpuro-
Krox20-HA or pMSCVpuro-HA as a control. The pRL-TK (from Promega)
that carries rennila luciferase was also cotransfected as an internal control
for transfection efficiency. Cells were cultured till 2 day postconfluence and
exposed to either the differentiation cocktail (1 g/ml insulin, 0.25 g/ml
dexamethasone, 0.5 mM IBMX), or culture media devoid of inducers as a
control. At 12 hr postinduction, cells were harvested and luciferase activities
analyzed using the Promega Dual-Luciferase assay kit as recommended by
the manufacturer.
Supplemental data
Supplemental data include one figure and can be found with this article
online at http://www.cellmetabolism.org/cgi/content/full/1/2/93/DC1.
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